In this #JACCCardioOnc review, the authors highlight the established cardioprotective benefits of #SGLT2i in #heartfailure and review emerging preclinical and clinical evidence supporting their potential role in #CardioOnc. https://t.co/5HwXL0RJoZ @Zordoky_Lab@BlaesAnneMD
Merry Christmas and Happy Holidays from NIH! 🌟
Wishing you peace, joy, and good health this holiday season! 🌟🎄
From all of us at NIH, thank you for supporting science and discovery. 🔬 🧪
#MerryChristmas#HappyHolidays#NIH
🚨 We are delighted to welcome Dr. Beshay Zordoky to the Editorial Board of the Journal of Cardiovascular Aging! 🎉
Welcome aboard, Dr. Zordoky! 💼🫀
#Cardiotoxicity#CancerSurvivorship#AgingResearch
.@NIHDirector_Jay and Dr. @NKleinstreuer talk about NIH’s shift toward human-focused research and how NIH will no longer issue NOFOs exclusively for animal models.
Watch the latest episode of The Director’s Desk to hear more: https://t.co/BRrHQuMfGL
Cardiovascular toxicity of breast cancer treatments: from understandin... https://t.co/MamsIjAcek
Exciting year at ASCO 2025 with new treatment options for those living with advanced breast cancer - let’s not forget about the impact on cardiovascular health. @ASCO@ICOSociety
Very glad to see our recent work in press at @CircAHA . Alternatively activated macrophages driven by IL-4 signaling sustain a parainflammatory response in the failing heart. Kudos to @QiongxinWang for her tireless work on this study
Take a look at our latest article! It's the first fruit of my collaboration with @CamellChristina. Stay tuned, many more to come
https://t.co/hrhGPrmaI8
We're gathering on April 12 for the 2025 Survivorship Conference with special guest speaker Dr. Wendy S. Harpham, a physician-survivor who will share personal stories and offer insights and tips on how to find healing hope.
https://t.co/cESQMIV6QU